Pre‐analytical influence on the low molecular weight cerebrospinal fluid proteome
- 28 June 2007
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 1 (7) , 699-711
- https://doi.org/10.1002/prca.200700126
Abstract
Cerebrospinal fluid (CSF) is a perfect source to search for new biomarkers to improve early diagnosis of neurological diseases. Standardization of pre‐analytical handling of the sample is, however, important to obtain acceptable analytical quality. In the present study, MALDI‐TOF MS was used to examine the influence of pre‐analytical sample procedures on the low molecular weight (MW) CSF proteome. Different storage conditions like temperature and duration or the addition of as little as 0.2 µL blood/mL neat CSF caused significant changes in the mass spectra. The performance of different types of MW cut‐off spin cartridges from different suppliers used to enrich the low MW CSF proteome showed great variance in cut‐off accuracy, stability and reproducibility. The described analytical method achieved a polypeptide discriminating limit of approximately 800 pM, two to three orders of magnitude lower than reported for plasma. Based on this study, we recommend that CSF is centrifuged immediately after sampling, prior to storage at –80ºC without addition of protease inhibitors. Guanidinium hydrochloride is preferred to break protein‐protein interactions. A spin cartridge with cut‐off limit above the intended analytical mass range is recommended. Our study contributes to the important task of developing standardized pre‐analytical protocols for the proteomic study of CSF.Keywords
This publication has 28 references indexed in Scilit:
- A combined dataset of human cerebrospinal fluid proteins identified by multi‐dimensional chromatography and tandem mass spectrometryProteomics, 2007
- The Proteomic Search for Diagnostic BiomarkersMolecular & Cellular Proteomics, 2006
- Protein biomarker discovery and validation: the long and uncertain path to clinical utilityNature Biotechnology, 2006
- Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profilingProteomics, 2006
- Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide displayProteomics, 2005
- Artifactual Isoform Profile Modification Following Treatment of Human Plasma or Serum with Protease Inhibitor, Monitored by 2-Dimensional Electrophoresis and Mass SpectrometryBioTechniques, 2005
- The impact of blood contamination on the proteome of cerebrospinal fluidProteomics, 2005
- Can Mass Spectrometric Protein Profiling Meet Desired Standards of Clinical Laboratory Practice?Clinical Chemistry, 2005
- Mass Spectrometry-based Diagnostics: The Upcoming Revolution in Disease DetectionClinical Chemistry, 2003
- Preprocessing of analytical profiles in the presence of homoscedastic or heteroscedastic noiseAnalytical Chemistry, 1994